Precision Medicine Market Growth, Trends, and Forecast by 2031

Coverage: By Technology (Drug Discovery, Companion Diagnostics, Gene Sequencing, Bio-Informatics, Big Data Analytics); Application (Oncology, Respiratory, CNS, Infectious Diseases, Immunology, Cardiology, Other Applications) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2023 | Base Year: 2024 | Forecast Period: 2025-2031
  • Status : Data Released
  • Report Code : TIPBT00002184
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : January 27, 2025
Precision Medicine Market Growth, Trends, and Forecast by 2031
Report Date: January 27, 2025   |   Report Code: TIPBT00002184 Email: sales@theinsightpartners.com

2024 Market Size

US$ 116.70 Bn

Base year value

2031 Forecast

US$ 271.17 Bn

Projected by 2031

CAGR 2025-2031

12.8 %

Growth rate

Addressable Market

US$ 1,361.23 Bn

(2025-2031)

The Precision Medicine Market size is expected to reach US$ 271.17 billion by 2031. The market is anticipated to register a CAGR of 12.8% during 2025–2031.

The Precision Medicine Market is categorized by technology into the following subsegments: Drug Discovery, Companion Diagnostics, Gene Sequencing, Bio-Informatics, Big Data Analytics. It further presents an analysis based on application, i.e., Oncology, Respiratory, CNS, Infectious Diseases, Immunology, Cardiology, Other Applications. The global analysis is broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.

Purpose of the Report

The report Precision Medicine Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Precision Medicine Market Segmentation Technology

  1. Drug Discovery
  2. Companion Diagnostics
  3. Gene Sequencing
  4. Bio-Informatics
  5. Big Data Analytics

Application

  1. Oncology
  2. Respiratory
  3. CNS
  4. Infectious Diseases
  5. Immunology
  6. Cardiology
  7. Other Applications

Market Assessment and Insights

  • Global market for Precision Medicine was valued at US$ 116.70 Billion in 2024
  • Annual market size is expected to reach US$ 271.17 Billion by 2031
  • Total addressable market (TAM) during 2025-2031 is projected to reach approximately US$ 1,361.23 Billion
  • Market is anticipated to register a CAGR of 12.8% during the forecast period
  • The United States represents a key market, supported by Genomic and Molecular Biology, The Growth of Chronic Diseases and Cancer, Broad Regulatory Approval, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Expanding oncology, Generation of Targeted Therapies for Rare Diseases, Expanded Markets are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, Novartis AG, Bristol-Myers Squibb Company, Medtronic, QIAGEN, Pfizer Inc., Thermo Fisher Scientific Inc., Eli Lilly and Company, AstraZeneca, OneOme LLC, Kailos Genetics Inc., Syapse Inc., BioSyntagma, Biogen, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Precision Medicine Market: Strategic Insights

precision-medicine-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Precision Medicine Market Growth Drivers

  1. Genomic and Molecular Biology: Genomic and molecular biology are the engines for precision medicine. The sequencing and interpretation of genetic material led to personalised treatments in which therapies are individualised by genetic code, lifestyle and environment. A rising consciousness of the human genome is opening up new therapeutic applications for precision medicine in oncology, rare diseases and chronic disease.
  2. The Growth of Chronic Diseases and Cancer: Growing chronic diseases such as cancer, cardiovascular disease, diabetes and so on are driving the precision medicine. The more patients who want to be treated based on their own genetic characteristics, the more needed personalized treatments and genetic tests that could lead to better patient outcomes.
  3. Broad Regulatory Approval: Governments like FDA and EMA have gotten more open to precision medicine, allowing targeted treatments and companion diagnostics to allow for tailor-made treatment plans. Not only do these regulatory approvals fuel precision medicine’s advancement, they also provide reason to be optimistic about its clinical use.

Precision Medicine Market Future Trends

  1. Application of AI/Big Data: Artificial intelligence (AI) and big data are transforming precision medicine. The algorithms of AI are examining patient data — genomics, clinical records, imaging data — to find patterns and predict patient outcomes. This is also driving the uptake of precision medicine in the clinic.
  2. Expansion of Companion Diagnostics: Companion diagnostics, which are test results that determine how a patient will respond to a particular therapy, are on the rise. With ever more precise treatments being developed, precision medicine enlists companion diagnostics to guide therapy choices. We see this pattern in oncology, where a set of mutations and biomarkers sets the most effective therapies.
  3. A Move to Preventive Medicine: Precision medicine is not only about diagnosing but also about preventing diseases. It’s when genetic risk factors are found in advance that clinicians can customize preventive interventions. This prevention, post-treatment revolution is a widespread medical phenomenon, especially with cancer, heart disease, and rare genetic conditions.

Precision Medicine Market Opportunities

  1. Expanding oncology: Precision oncology is one of the biggest expansions in precision medicine. Targeted cancer therapies that can be designed according to genetic mutations and biomarkers are changing cancer therapy. The number of FDA-approved precision oncology drugs is on the rise, and there is huge market opportunity for genetic testing, biomarker discovery, and individualised cancer therapies.
  2. Generation of Targeted Therapies for Rare Diseases: Precision medicine is promising for rare genetic diseases where no current treatments exist. A patient’s genetic profile allows the development of a tailored therapy to offer patients permanent relief for these unmet needs.
  3. Expanded Markets: Precision medicine is not just expanding in developed markets but also in emerging markets. Precision medicine will continue to grow as healthcare systems in the Asia-Pacific and Latin America evolve and invest in the most advanced technologies thereby opening up new revenue for diagnostics companies, pharma and biotech firms.

Precision Medicine Market Report Scope

Report Attribute Details
Market size in 2024 US$ 116.70 Billion
Market Size by 2031 US$ 271.17 Billion
Global CAGR (2025 - 2031) 12.8%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Technology
  • Drug Discovery
  • Companion Diagnostics
  • Gene Sequencing
  • Bio-Informatics
  • Big Data Analytics
By Application
  • Oncology
  • Respiratory
  • CNS
  • Infectious Diseases
  • Immunology
  • Cardiology
  • Other Applications
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • F. Hoffmann-La Roche Ltd
  • Quest Diagnostics Incorporated
  • Novartis AG
  • Bristol-Myers Squibb Company
  • Medtronic
  • QIAGEN
  • Pfizer Inc.
  • Thermo Fisher Scientific Inc.
  • Eli Lilly and Company
  • AstraZeneca
  • OneOme LLC
  • Kailos Genetics Inc.
  • Syapse Inc.
  • BioSyntagma
  • Biogen

Precision Medicine Market Players Density: Understanding Its Impact on Business Dynamics

The Precision Medicine Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

precision-medicine-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Precision Medicine Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Precision Medicine Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

The leading players are F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, Novartis AG, Bristol-Myers Squibb Company, Medtronic, QIAGEN, Pfizer Inc., Thermo Fisher Scientific Inc., Eli Lilly and Company, AstraZeneca,

The market is expected to register a CAGR of 12.8% during 2025-2031.

Rapidly rising healthcare expenditure, advancement in genetic testing, migration towards personalized treatments, and integration of big data and AI in healthcare are the prime growth factors for Precision Medicine Market.

Future trends include increased use of genomic data in developing tailored treatments, expansion of personalized cancer therapies, and increased integration of AI and machine learning in drug development.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA